Literature DB >> 10508699

APC: the plot thickens.

M Bienz1.   

Abstract

Adenomatous polyposis coli (APC) is an important tumour suppressor in the human colon. It is conserved between human and flies, and promotes, together with Axin and glycogen synthase kinase 3 (GSK3), the degradation of the Wnt-signalling effector beta-catenin. Recent experiments have shaped our understanding of how Axin and GSK3 function but the role of APC in this process remains elusive.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508699     DOI: 10.1016/s0959-437x(99)00016-7

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  19 in total

1.  Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes.

Authors:  R Houlston; M Crabtree; R Phillips; M Crabtree; I Tomlinson
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

2.  gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.

Authors:  F T Kolligs; B Kolligs; K M Hajra; G Hu; M Tani; K R Cho; E R Fearon
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

Review 3.  The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinoma.

Authors:  Elena Tassi; Anton Wellstein
Journal:  Semin Oncol       Date:  2006-12       Impact factor: 4.929

4.  Seven Wnt homologues in Drosophila: a case study of the developing tracheae.

Authors:  M Llimargas; P A Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

5.  Actin-dependent membrane association of the APC tumour suppressor in polarized mammalian epithelial cells.

Authors:  R Rosin-Arbesfeld; G Ihrke; M Bienz
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

6.  Capsaicin represses transcriptional activity of β-catenin in human colorectal cancer cells.

Authors:  Seong-Ho Lee; Raphael L Richardson; Roderick H Dashwood; Seung Joon Baek
Journal:  J Nutr Biochem       Date:  2011-07-20       Impact factor: 6.048

7.  Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.

Authors:  A Danilkovitch-Miagkova; A Miagkov; A Skeel; N Nakaigawa; B Zbar; E J Leonard
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

8.  Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein.

Authors:  K Tago; T Nakamura; M Nishita; J Hyodo; S Nagai; Y Murata; S Adachi; S Ohwada; Y Morishita; H Shibuya; T Akiyama
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

9.  Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.

Authors:  A Damalas; S Kahan; M Shtutman; A Ben-Ze'ev; M Oren
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

10.  Tumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas -.

Authors:  Elena Tassi; Anton Wellstein
Journal:  Cancer Res Treat       Date:  2006-12-31       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.